ABSTRACT International Worm Meeting 2001 A screen for new Hic mutants Michael Dybbs and Joshua Kaplan 361 LSA, Dept. of Mol. and Cell Biology, University of California, Berkeley, CA 94720 Previous studies by our lab and others have shown that release of acetylcholine at the C. elegans neuromuscular junction (NMJ) is regulated by a G-protein signaling network. These studies have shown that serotoninergic signaling through
goa-1 G a o and
dgk-1 DAG kinase inhibits acetylcholine release. An opposing muscarinic signaling pathway through
egl-30 G a q and
egl-8 PLC b enhances acetylcholine release via the production of diacylglycerol ( DAG). Two RGS proteins,
egl-10 RGS and
eat-16 RGS, further regulate this pathway by stimulating the GTPase activity of goa- 1 G a o (
eat-16 RGS) and
egl-30 G a q (
egl-10 RGS). Mutations in the inhibitory pathway (
goa-1 ,
dgk-1 ) make animals hypersensitive to paralysis by the acetylcholine esterase inhibitor, aldicarb (Hic) Mutations in the muscarinic pathway (
egl-30 ,
egl-8 ) make animals resistant to aldicarb (Ric). In order to identify additional molecules which negatively regulate release, we are conducting a broad screen for Hic mutants. Aldicarb sensitivity could be a result of either mutations that effect presynaptic neurotransmitter release or postsynaptic response to neurotransmitter in the muscle. We are distinguishing these effects using levamisole, a cholinergic agonist that acts directly on the acetylcholine receptors in the muscle. We are focusing on mutants that display a wild-type muscle sensitivity and are thus acting presynaptically. Mutants isolated in our pilots screens will be described.